MedTrace Logo

Donors After Cardiac Death: Validating Identification Criteria

NCT00177606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2017-05-31

No results posted yet for this study

Summary

The purpose of this study is to validate a set of proposed clinical criteria that have been designed to identify patients who will die rapidly following the elective removal of life sustaining treatments.

Conditions

  • Withdrawing Treatment

Interventions

BEHAVIORAL

withdrawal of life sustaining treatments

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Michael A DeVita, MD · University of Pittsburgh/University of Pittsburgh Medical Center

  • Christine Zowistowski, MD · University of Tennesse, Memphis

  • Maria Brooks, PhD · University of Pittsburgh

Eligibility

Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00177606 on ClinicalTrials.gov